A new investigation indicates an inexpensive drug could substantially decrease the danger of esophageal cancer. The Gazeta Express detailed this finding on March 16, 2026, at 7:54 PM. Researchers have discovered that a commonly accessible medication, priced around two euros per tablet, can significantly reduce the probability of this devastating illness.
This drug is Metformin, routinely prescribed to millions managing type 2 diabetes and their blood sugar levels. The study’s results suggest Metformin may diminish the risk of esophageal cancer by more than a third. Published in the JAMA Network Open scientific journal, the research highlights the potential benefit for individuals at elevated risk.
Specifically, those with a prolonged history of acid reflux are identified as being particularly vulnerable. Experts now propose utilizing Metformin for preventative measures in high-risk populations. This finding offers a promising avenue for mitigating the serious health threat posed by esophageal cancer.
The research underscores the importance of considering this readily available medication as a tool to lower the overall risk.
Topics: #risk #esophageal #cancer